Cargando…

Baseline MELD Score Predicts Hepatic Decompensation during Antiviral Therapy in Patients with Chronic Hepatitis C and Advanced Cirrhosis

BACKGROUND AND AIMS: In patients with advanced liver cirrhosis due to chronic hepatitis C virus (HCV) infection antiviral therapy with peginterferon and ribavirin is feasible in selected cases only due to potentially life-threatening side effects. However, predictive factors associated with hepatic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dultz, Georg, Seelhof, Martin, Herrmann, Eva, Welker, Martin-Walter, Friedrich-Rust, Mireen, Teuber, Gerlinde, Kronenberger, Bernd, von Wagner, Michael, Vermehren, Johannes, Sarrazin, Christoph, Zeuzem, Stefan, Hofmann, Wolf Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731309/ https://www.ncbi.nlm.nih.gov/pubmed/23936497 http://dx.doi.org/10.1371/journal.pone.0071262

Ejemplares similares

Serum Sphingolipid Variations Associate with Hepatic Decompensation and Survival in Patients with Cirrhosis
por: Grammatikos, Georgios, et al.
Publicado: (2015)

Point Shear‐Wave Elastography Using Acoustic Radiation Force Impulse Imaging for the Prediction of Liver‐Related Events in Patients With Chronic Viral Hepatitis
por: Hernandez Sampere, Lisa, et al.
Publicado: (2020)

Hepatitis C Clearance by Direct-Acting Antivirals Impacts Glucose and Lipid Homeostasis
por: Graf, Christiana, et al.
Publicado: (2020)

Liver transplantation for chronic hepatitis C virus infection in the United States 2002–2014: An analysis of the UNOS/OPTN registry
por: Dultz, Georg, et al.
Publicado: (2017)

Serum MicroRNA-21 as Marker for Necroinflammation in Hepatitis C Patients with and without Hepatocellular Carcinoma
por: Bihrer, Verena, et al.
Publicado: (2011)

Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis
por: Cheng, Xiang-Pu, et al.
Publicado: (2016)

Diagnostic and prognostic significance of cell death markers in patients with cirrhosis and acute decompensation
por: Stoffers, Philipp, et al.
Publicado: (2022)

Soluble Serum CD81 Is Elevated in Patients with Chronic Hepatitis C and Correlates with Alanine Aminotransferase Serum Activity
por: Welker, Martin-Walter, et al.
Publicado: (2012)

Assessment of liver fibrosis and associated risk factors in HIV-infected individuals using transient elastography and serum biomarkers
por: Vermehren, Johannes, et al.
Publicado: (2012)

Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis
por: Friedrich-Rust, Mireen, et al.
Publicado: (2010)

Concise review: Interferon-free treatment of hepatitis C virus-associated cirrhosis and liver graft infection
por: Weiler, Nina, et al.
Publicado: (2016)

Treatment of Hepatitis B in Decompensated Liver Cirrhosis
por: Guan, Richard, et al.
Publicado: (2011)

Correlation of Model for End Stage Liver Disease (MELD), MELD-Sodium (MELD-Na), and Child-Turcotte-Pugh (CTP) Score With Frailty in Patients With Hepatitis C Virus (HCV) Related Cirrhosis
por: Panezai, Muhammad Qaiser, et al.
Publicado: (2023)

Inclusion of Sarcopenia Within MELD (MELD-Sarcopenia) and the Prediction of Mortality in Patients With Cirrhosis
por: Montano-Loza, Aldo J, et al.
Publicado: (2015)

Vitamin D deficiency is associated with hepatic decompensation and inflammation in patients with liver cirrhosis: A prospective cohort study
por: Kubesch, Alica, et al.
Publicado: (2018)

Recompensation of Decompensated Hepatitis B Cirrhosis: Current Status and Challenges
por: Zhao, Hong, et al.
Publicado: (2020)

Evolution of care in cirrhosis: Preventing hepatic decompensation through pharmacotherapy
por: Lee, Seohyuk, et al.
Publicado: (2023)

Impact of sarcopenia on prognostic value of cirrhosis: going beyond the hepatic venous pressure gradient and MELD score
por: Kang, Seong Hee, et al.
Publicado: (2018)

SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation
por: Kaplan, David E., et al.
Publicado: (2021)

New hepatitis C therapies in clinical development
por: Vermehren, Johannes, et al.
Publicado: (2011)

Model for End Stage Liver Disease (MELD) Score: A Tool for Prognosis and Prediction of Mortality in Patients With Decompensated Liver Cirrhosis
por: Emenena, Isioma, et al.
Publicado: (2023)

Hepatic Myelopathy in a Patient with Decompensated Alcoholic Cirrhosis and Portal Colopathy
por: Premkumar, Madhumita, et al.
Publicado: (2012)

Sofosbuvir and ribavirin in acute hepatitis C–infected patient with decompensated cirrhosis
por: Liu, Hui, et al.
Publicado: (2016)

Invasive pulmonary mucormycosis and aspergillosis in a patient with decompensated hepatic cirrhosis
por: Persichino, Jon G., et al.
Publicado: (2018)

Safety and efficacy of tenofovir in chronic hepatitis B-related decompensated cirrhosis
por: Lee, Soon Kyu, et al.
Publicado: (2017)

Postoperative Risk of Hepatic Decompensation after Orthopedic Surgery in Patients with Cirrhosis
por: Nyberg, Eric M., et al.
Publicado: (2016)

Serum liver fibrosis markers predict hepatic decompensation in compensated cirrhosis
por: Chen, Qingling, et al.
Publicado: (2023)

MELD-GRAIL-Na Is a Better Predictor of Mortality Than MELD in Korean Patients with Cirrhosis
por: Kim, Jung-Woo, et al.
Publicado: (2023)

Evaluation of the Integrated Pulmonary Index® during non-anesthesiologist sedation for percutaneous endoscopic gastrostomy
por: Michael, Florian Alexander, et al.
Publicado: (2020)

Resolution of ascites and hepatic encephalopathy and absence of variceal bleeding in decompensated hepatitis C virus cirrhosis patients
por: Romano, John, et al.
Publicado: (2018)

Chemical pleurodesis for the management of refractory hepatic hydrothorax in patients with decompensated liver cirrhosis
por: Lee, Woo Jin, et al.
Publicado: (2011)

The impact of newer nucleos(t)ide analogues on patients with hepatitis B decompensated cirrhosis
por: Cholongitas, Evangelos, et al.
Publicado: (2015)

Entecavir for Patients with Hepatitis B Decompensated Cirrhosis in China: a meta-analysis
por: Wang, F.Y., et al.
Publicado: (2016)

Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis
por: De Roza, Marianne Anastasia, et al.
Publicado: (2019)

A bite difficult to heal: Pasteurella multocida induced decompensated hepatic cirrhosis
por: Patel, Hiren, et al.
Publicado: (2021)

Comparison of the Prognosis of Decompensated Cirrhosis in Patients with and Without Eradication of Hepatitis C Virus
por: Kumada, Takashi, et al.
Publicado: (2021)

Acute-on-chronic liver failure (ACLF) precipitated by severe alcoholic hepatitis: another collateral damage of the COVID-19 pandemic?
por: Görgülü, Esra, et al.
Publicado: (2022)

Interobserver Agreement of Thyroid Imaging Reporting and Data System (TIRADS) and Strain Elastography for the Assessment of Thyroid Nodules
por: Friedrich-Rust, Mireen, et al.
Publicado: (2013)

A Common HLA-DPA1 Variant Is Associated with Hepatitis B Virus Infection but Fails to Distinguish Active from Inactive Caucasian Carriers
por: Vermehren, Johannes, et al.
Publicado: (2012)

Absence of HBV Reactivation in Patients With Resolved HBV Infection Following DAA Therapy for Hepatitis C: A 1-Year Follow-up Study
por: Mücke, Marcus M, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fsu08ksfijmo3dr3p9dorfs1et